tirzepatide grand junction co IV Services Medical Weight Loss | Bare

Description

Tirzepatide is a dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist approved by the FDA for the treatment of type 2 diabetes mellitus (brand name Mounjaro) and chronic weight management (brand name Zepbound)

Silva specializes in evidence-based weight management, including GLP-1 and GIP therapies such as semaglutide and tirzepatide

These patterns may reflect shifts in prescribing behavior following updated coverage

Product Specifications: Active Compound: Tirzepatide Strength: 30mg Brand: Body Pharm Category: Weight Loss Peptide Quality: Pharmaceutical Grade Testing: Third-Party Lab Verified Usage Guidelines & Information Important: Always consult with a healthcare professional before use